Category Archives: CEO

Eric Lefkosfky Uses Data at Tempus to Cure Cancer

Tempus co-founder, president and chief executive officer, Eric Lefkofsky is very passionate about finding cure and treatment for cancer. Tempus uses advanced technology to come up with more effective ways of fighting this malignant disease. Eric Lefkofsky also established other technology companies such as Uptake Technologies which he launched alongside other co-founders.

Mr. Eric is also a generous giver who cares about the needs of the people in the society. This made him come up with an organization called Lefkosky Family Foundation which he co-founded with his beloved wife Liz. This charitable organization has been functional since 2006. Basically, the couple’s aim was to change the livelihoods of many people who are not able to make ends meet and since are not in a position to provide daily bread for their families.

Most importantly, Eric Lefkosky learned the need to dig deep into cancer when he couldn’t bear the suffering of a loved one due to this life-threatening disease. Recently, the Dartmouth researchers have come up with a study that provides a better approach towards cancer. The study has revealed that the cancer genes exist within our bodies and the different alterations and mutations that occur within the DNA increases risks of suffering from the disease.

He has merged the University of Chicago and Tempus in the quest for finding treatment for cancer with the use of data. Eric performs cancer sequencing for cancer patients at his technological laboratories at Tempus. He then sends feedback to the oncologists at the university who analyze these results hence recommending effective treatment. Eric’s venture is actually not money oriented but mostly aiming at providing love and care for these cancer patients. His staffs have proved to be very compassionate as well.

The study was majorly based on causes of lung cancer among many smokers. Being that the risks involved are related to Single-Stranded Polymorphism, SNPs, scientists have manipulated the structures and altered their functioning to make biomarkers.

The data obtained in the analysis of the functioning of the genes and the physical properties of these smokers originated from OncoArray Consortium. The advantageous bit of this study is that researchers can use these SNPs to classify the symptoms and the consequences that smokers get themselves into. This has made it easier for them to understand the various types of cancer hence leading to advanced and quality diagnosis.

As a result, cancer patients are now exposed to a variety of treatment options depending on the stages of the lung cancer. This discovery provides hope for a better understanding of the disease in the near future.

https://www.facebook.com/eplefkofsky/